ANI Pharma Inc (ANIP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
06-2009 | 03-2009 | 12-2008 | 09-2008 | 06-2008 | |
Sales | 115 | 68 | 3,610 | 82 | 26 |
Gross Profit | 115 | 68 | 3,610 | 82 | 26 |
Operating Expenses | 4,736 | 4,131 | 5,469 | 6,773 | 5,540 |
Operating Income | -4,621 | -4,062 | -1,859 | -6,691 | -5,514 |
Other Income | 0 | 12 | 694 | 106 | -534 |
Pre-tax Income | -4,621 | -4,051 | -1,165 | -6,585 | -6,048 |
Net Income Continuous | -4,621 | -4,051 | -1,165 | -6,585 | -6,048 |
Net Income | $-4,621 | $-4,051 | $-1,165 | $-6,585 | $-6,048 |
EPS Basic Total Ops | -6.12 | -5.40 | -1.80 | -8.64 | -7.92 |
EPS Basic Continuous Ops | -6.06 | -5.31 | -1.52 | -8.65 | -7.99 |
EPS Diluted Total Ops | -6.12 | -5.40 | -1.80 | -8.64 | -7.92 |
EPS Diluted Continuous Ops | -6.06 | -5.31 | -1.52 | -8.65 | -7.99 |
EBITDA(a) | $-4,587 | $-4,033 | $-1,850 | $-6,679 | $-5,501 |